carcinoma,liver,cancer

Mashup Score: 0

Phase 2 Study Evaluates Serplulimab Plus HLX04 as First-Line Treatment for Advanced Hepatocellular Carcinoma - 9 hour(s) ago

Serplulimab plus HLX04 demonstrates a favorable safety profile in patients with advanced hepatocellular carcinoma.

Source: www.pharmacytimes.com

Categories: General Medicine News, General Journals & Societ

Tweet Tweets with this article
- Pharmacy_Times
  
  A phase 2 study highlights the potential of serplulimab combined with HLX04 as a first-line treatment for advanced hepatocellular #carcinoma, offering a potentially new, effective option for #liver #cancer care. Learn moreL https://t.co/HI2PH8mYtw